Evidence map›Paper›PMID 36445937›Full record

ArticleScience signaling2022

VPS34-dependent control of apical membrane function of proximal tubule cells and nutrient recovery by the kidney.

Markus M Rinschen, Jennifer L Harder, Madalina E Carter-Timofte, Luis Zanon Rodriguez, Carmen Mirabelli, Fatih Demir, Naziia Kurmasheva, Suresh K Ramakrishnan, Madlen Kunke, Yifan Tan and 15 more

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Glutaminolysis is a Potential Therapeutic Target for Kidney Diseases.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 4 countries.

Markus M RinschenScripps Center for Metabolomics, Scripps Research, La Jolla, CA 92037, USA.ORCID 0000-0002-9252-1342
Jennifer L HarderDivision of Nephrology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0002-7927-608X
Madalina E Carter-TimofteDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-1752-2820
Luis Zanon RodriguezDepartment of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.ORCID 0000-0001-9708-0104
Carmen MirabelliDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0002-4785-5482
Fatih DemirDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-5744-0205
Naziia KurmashevaDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-9609-5811
Suresh K RamakrishnanDepartment of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.
Madlen KunkeDepartment of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.
Yifan TanDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-7322-297X
Anja BillingDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-5770-5496
Eileen DahlkeDepartment of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.
Alexey A LarionovDepartment of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.ORCID 0000-0001-6902-8878
Wibke Bechtel-WalzIV Department of Medicine and Faculty of Medicine, University Medical Center Freiburg, 79110 Freiburg, Germany.ORCID 0000-0001-6032-3627
Ute AukschunIV Department of Medicine and Faculty of Medicine, University Medical Center Freiburg, 79110 Freiburg, Germany.ORCID 0000-0003-2547-394X
Marlen GrabbeIV Department of Medicine and Faculty of Medicine, University Medical Center Freiburg, 79110 Freiburg, Germany.
Rikke NielsenDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Erik I ChristensenDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0003-0684-5162
Matthias KretzlerDivision of Nephrology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0003-4064-0582
Tobias B HuberIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.ORCID 0000-0001-7175-5062
Christiane E WobusDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0001-5286-0924
David OlagnierDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0001-6912-0674
Gary SiuzdakScripps Center for Metabolomics, Scripps Research, La Jolla, CA 92037, USA.ORCID 0000-0002-4749-0014
Florian GrahammerIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.ORCID 0000-0002-7851-754X
Franziska TheiligDepartment of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.ORCID 0000-0001-8810-4717
Aarhus University · DKUniversity of Michigan · USChristian-Albrechts-Universität zu Kiel · DEUniversity Medical Center Freiburg · DEUniversity of Fribourg · CHScripps Institution of Oceanography · USUniversität Hamburg · DE

Funding

University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological SystemsUG3TR003288 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, KRETZLER, MATTHIAS · 2020 to 2021
$1.7M
NCATS NIH HHS UG3 TR003288NIDDK NIH HHS P30 DK081943
6 · The paper itself

Abstract

The lipid kinase VPS34 orchestrates autophagy, endocytosis, and metabolism and is implicated in cancer and metabolic disease. The proximal tubule in the kidney is a key metabolic organ that controls reabsorption of nutrients such as fatty acids, amino acids, sugars, and proteins. Here, by combining metabolomics, proteomics, and phosphoproteomics analyses with functional and superresolution imaging assays of mice with an inducible deficiency in proximal tubular cells, we revealed that VPS34 controlled the metabolome of the proximal tubule. In addition to inhibiting pinocytosis and autophagy, VPS34 depletion induced membrane exocytosis and reduced the abundance of the retromer complex necessary for proper membrane recycling and lipid retention, leading to a loss of fuel and biomass. Integration of omics data into a kidney cell metabolomic model demonstrated that VPS34 deficiency increased β-oxidation, reduced gluconeogenesis, and enhanced the use of glutamine for energy consumption. Furthermore, the omics datasets revealed that VPS34 depletion triggered an antiviral response that included a decrease in the abundance of apically localized virus receptors such as ACE2. VPS34 inhibition abrogated SARS-CoV-2 infection in human kidney organoids and cultured proximal tubule cells in a glutamine-dependent manner. Thus, our results demonstrate that VPS34 adjusts endocytosis, nutrient transport, autophagy, and antiviral responses in proximal tubule cells in the kidney.

Indexed as

COVID-19GlutamineAnimalsAntiviral AgentsHumansKidneyLipidsMiceNutrientsSARS-CoV-2Antiviral AgentsGlutamineLipidsNutrients

Identifiers

PMID36445937
PMCPMC10350314
OpenAlexW4310358170

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.